BR9910405A - Fenilssulfonamida-feniletilaminas úteis como receptores de dopamina - Google Patents

Fenilssulfonamida-feniletilaminas úteis como receptores de dopamina

Info

Publication number
BR9910405A
BR9910405A BR9910405-9A BR9910405A BR9910405A BR 9910405 A BR9910405 A BR 9910405A BR 9910405 A BR9910405 A BR 9910405A BR 9910405 A BR9910405 A BR 9910405A
Authority
BR
Brazil
Prior art keywords
useful
dopamine receptors
phenylethylamines
phenylsulfonamide
alkyl
Prior art date
Application number
BR9910405-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Arthur Glenn Romero
Jeffrey A Leiby
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BR9910405A publication Critical patent/BR9910405A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46Y being a hydrogen or a carbon atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9910405-9A 1998-05-14 1999-05-07 Fenilssulfonamida-feniletilaminas úteis como receptores de dopamina BR9910405A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8549398P 1998-05-14 1998-05-14
PCT/US1999/007023 WO1999058499A1 (en) 1998-05-14 1999-05-07 Phenylsulfonamide-phenylethylamines useful as dopamine receptors

Publications (1)

Publication Number Publication Date
BR9910405A true BR9910405A (pt) 2001-01-09

Family

ID=22191975

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910405-9A BR9910405A (pt) 1998-05-14 1999-05-07 Fenilssulfonamida-feniletilaminas úteis como receptores de dopamina

Country Status (24)

Country Link
US (1) US6103766A (https=)
EP (1) EP1077935B1 (https=)
JP (1) JP2002514623A (https=)
KR (1) KR20010043546A (https=)
CN (1) CN1152857C (https=)
AT (1) ATE253045T1 (https=)
AU (1) AU752543B2 (https=)
BR (1) BR9910405A (https=)
CA (1) CA2327345A1 (https=)
DE (1) DE69912419T2 (https=)
DK (1) DK1077935T3 (https=)
EA (1) EA002918B1 (https=)
ES (1) ES2211078T3 (https=)
HU (1) HUP0101746A3 (https=)
IL (1) IL139263A0 (https=)
NO (1) NO20005732L (https=)
NZ (1) NZ508152A (https=)
PL (1) PL343891A1 (https=)
PT (1) PT1077935E (https=)
SK (1) SK16242000A3 (https=)
TR (1) TR200003325T2 (https=)
TW (1) TW450954B (https=)
WO (1) WO1999058499A1 (https=)
ZA (1) ZA200005921B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2300119T3 (es) * 1997-02-27 2008-06-01 Takeda Pharmaceutical Company Limited Compuestos de amina, su produccion y su uso como inhibidores de la produccion de beta-amiloide.
WO2002089785A1 (en) * 2001-05-07 2002-11-14 Smithkline Beecham Corporation Sulfonamides
WO2002089740A2 (en) * 2001-05-07 2002-11-14 Smithkline Beecham Corporation Sulfonamides
EP1812389B1 (en) 2004-10-14 2011-08-17 Abbott GmbH & Co. KG Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
CA2583983C (en) 2004-10-14 2013-07-16 Abbott Gmbh & Co. Kg Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
ATE540922T1 (de) 2004-10-14 2012-01-15 Abbott Gmbh & Co Kg Zur behandlung von erkrankungen, die auf eine modulation des dopamin-d3-rezeptors ansprechen, geeignete aminoethylaromatische verbindungen
ATE496031T1 (de) * 2006-04-14 2011-02-15 Abbott Gmbh & Co Kg Für die behandlung von auf die modulierung des dopamin-d3-rezeptors ansprechende erkrankungen geeignete aryloxyethylaminverbindungen
AR060462A1 (es) 2006-04-14 2008-06-18 Abbott Gmbh & Co Kg Compuestos de ariloxietilamina apropiados para tratar trastornos que responden a la modulacion del receptor de dopamina d3
BRPI0710177A2 (pt) 2006-04-19 2012-05-29 Abbott Gmbh & Co Kg arilsulfonas heterocìclicas adequadas para tratar distúrbios que respondem à modulação do receptor 5ht6 de serotonina
WO2007118900A1 (en) 2006-04-19 2007-10-25 Abbott Gmbh & Co. Kg Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
WO2008026046A1 (en) * 2006-08-30 2008-03-06 Pfizer Products Inc. Morpholine d3 dopamine antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574741A (en) * 1969-04-14 1971-04-13 Mead Johnson & Co Sulfonamidophenalkylamines
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
GB9402197D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Compounds
EP0793653A1 (en) * 1994-11-23 1997-09-10 Neurogen Corporation Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
WO1997043262A1 (en) * 1996-05-11 1997-11-20 Smithkline Beecham P.L.C. Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
US5922770A (en) * 1996-07-22 1999-07-13 Novo Nordisk A/S Compounds with growth hormone releasing properties
JPH1180156A (ja) * 1997-09-04 1999-03-26 Hokuriku Seiyaku Co Ltd 1−(置換アリール)アルキル−1h−イミダゾピリジン−4−アミン誘導体

Also Published As

Publication number Publication date
CN1297431A (zh) 2001-05-30
NZ508152A (en) 2003-03-28
US6103766A (en) 2000-08-15
WO1999058499A1 (en) 1999-11-18
DE69912419D1 (de) 2003-12-04
IL139263A0 (en) 2001-11-25
CA2327345A1 (en) 1999-11-18
HK1036049A1 (en) 2001-12-21
EA200001184A1 (ru) 2001-04-23
ZA200005921B (en) 2001-11-14
AU3741899A (en) 1999-11-29
PT1077935E (pt) 2004-03-31
NO20005732D0 (no) 2000-11-13
EP1077935B1 (en) 2003-10-29
EA002918B1 (ru) 2002-10-31
SK16242000A3 (sk) 2001-06-11
HUP0101746A3 (en) 2002-10-28
HUP0101746A2 (hu) 2002-03-28
PL343891A1 (en) 2001-09-10
DE69912419T2 (de) 2004-07-22
DK1077935T3 (da) 2004-02-16
ES2211078T3 (es) 2004-07-01
JP2002514623A (ja) 2002-05-21
CN1152857C (zh) 2004-06-09
ATE253045T1 (de) 2003-11-15
TR200003325T2 (tr) 2001-04-20
AU752543B2 (en) 2002-09-19
NO20005732L (no) 2000-11-13
KR20010043546A (ko) 2001-05-25
EP1077935A1 (en) 2001-02-28
TW450954B (en) 2001-08-21

Similar Documents

Publication Publication Date Title
BR0014733A (pt) Derivados éter biarìlico úteis como inibidores de recaptação de monoamina
BR9910405A (pt) Fenilssulfonamida-feniletilaminas úteis como receptores de dopamina
ECSP066520A (es) Derivados de dihidrobenzofuranilo alcanamina y métodos para su uso
BR0012951A (pt) Agonistas de retinóides seletivos
BR0011542A (pt) Compostos de fenoxipropilamina
NO943526D0 (no) Kinuklidin-derivater som substans P antagonister
ES2175161T3 (es) Derivados de piperazina como antagonistas de taquiquinina.
PE20010205A1 (es) Derivados 3-sustituido de 2-carboxiciclopropil glicina como agonistas de glutamato
BR0115291A (pt) Derivados de 2-fenilaminoimidazolina fenil cetona substituìdos como antagonistas de ip
BR9909253A (pt) Derivados de 2-ariletil-(piperidin-4-ilmetil) amina como antagonistas de receptor muscarìnico
DK0923542T3 (da) Arylsubstituerede cycliske aminer som selektive dopamin-D3-ligander
TR200401546T4 (tr) Piperazin türevleri, hazırlanmaları ve merkezi sinir sistemi (CNS) bozukluklarının tedavisinde kullanımları
BR0110247A (pt) Derivado de ciclohexilamina como antagonistas de receptor de nmda seletivos em subtipo
BR0007229A (pt) Aminoazaciclos heterocìclicos substituìdos úteis como agentes de sistema nervoso central
BR0009225A (pt) Uso de um antagonista de nmda de baixa afinidade,e, método para tratar ou prevenir a depressão emum mamìfero
CO5611124A2 (es) Derivados de benzofurano substituidos utiles en el tratamiento de desordenes hiper-proliferativos
BR0103210A (pt) Derivados de azabicicloalcano e suas utilizações terapêuticas
ECSP088398A (es) Compuestos tricíclicos útiles como agonistas de receptores de oxitocina
BR0010693A (pt) Derivados azaindol para tratamento de depressão
BR0013582A (pt) Agonistas retinóides seletivos para rar
ES2182509T3 (es) Derivados de n-ariloxietilamina para el tratamiento de la depresion.
PE20011260A1 (es) Derivados de sulfonamida
BRPI0409180A (pt) compostos de pirrol[1,2-b]piridazina e seus usos como antagonistas do receptor cfr-1
EA200001058A1 (ru) Новые способы лечения нервных расстройств
BR0208508A (pt) Derivados de ciclopropilindol como inibidores seletivos da captação de serotonina

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: C07C 311/21, C07C 311/29, C07C 311/44, A61K 31/18, A61K 31/63, A61P 25/16, A61P 25/18, A61P 25/22, A61P 25/24, A61P 25/00

Ipc: C07C 311/21 (2007.10), C07C 311/29 (2007.10), C07C

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.